Detection of PDGFRA mutations at exons 12 and 18 among chronic myeloid leukemia patients treated with imatinib mesylate
Imatinib mesylate (IM) resistance is an emerging and major challenge in the treatment of patients with chronic myeloid leukaemia (CML). Resistance toward IM can be divided into BCR-ABL dependent pathways and BCR-ABL independent pathway. In this study, the BCRABL independent pathway was investigated;...
| 第一著者: | |
|---|---|
| フォーマット: | 学位論文 |
| 言語: | 英語 |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | http://eprints.usm.my/39897/ |
| Abstract | Abstract here |